Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013. uri icon

Overview

publication date

  • November 13, 2013

Research

keywords

  • Acute Coronary Syndrome
  • Adenosine
  • Endpoint Determination
  • Platelet Aggregation Inhibitors
  • United States Food and Drug Administration

Identity

Scopus Document Identifier

  • 84891155362

Digital Object Identifier (DOI)

  • 10.1016/j.ijcard.2013.11.003

PubMed ID

  • 24299581

Additional Document Info

volume

  • 170

issue

  • 3